International Society for Pharmacoepidemiology
International Society for Pharmacoepidemiology
 

 
Online Registration for the 29th ICPE Now Open!

This August, Montréal welcomes the International Society for Pharmacoepidemiology (ISPE) and its 29th Annual International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) this August.

There are three registration deadlines - the sooner you register, the lower your registration rate will be!

Early Bird: July 15, 2013
Advanced: August 5, 2013
On-Site: August 25, 2013

Click here to Register Today!



Call for Abstracts: innovative patient-centered health outcomes research methodology and its application to the study of rare diseases or drugs/devices used to treat patients with rare diseases

The Effective Health Care Program within the US Department of Health and Human Services Agency for Healthcare Research and Quality is accepting abstract submissions for a journal supplement on research methods for evaluating patient health outcomes in rare diseases. The proposed supplement will focus on innovative patient-centered health outcomes research methodology and its application to rare diseases or drugs/devices used to treat such patients. Topics areas of interest include:

1. Rare disease patients health outcomes in clinical trials, including outcomes arising from novel trial designs, such as adaptive clinical trials or n-of-1 trials

2. Emerging data sources for observational research on rare disease patients health outcomes, including the process of data aggregation and building disease registries or federated data networks

3. Novel analytic methods for observational research and prospective observational monitoring for rare disease patients health outcomes

4. Integrating stakeholder involvement in assessing rare disease patient health outcomes, particularly studies that describe or test how patient-centered health outcomes can be applied to enhance the development or evaluation of therapeutics for rare diseases

5. Economic, regulatory, ethical, legal, and social issues related to the study of rare disease health outcomes. Authors may present empirical data or seek to collaborate in developing consensus statements outlining basic principles in these areas.

Proposals for original research articles and insightful reviews will be given highest priority. Submissions are encouraged from authors with expertise in a broad range of study designs and from across multiple disciplines, including authors with methodological expertise in clinical trials, health outcomes studies, health services research, health policy, biostatistics, epidemiology, social science, and qualitative research. The selected authors will be invited to submit a complete manuscript for peer-review and publication in the Journal of General Internal Medicine, a widely indexed journal with an international audience among practicing clinicians and general medical researchers.

Submissions are due by May 31, 2013.

More information and the submission form are available on the Effective Health Care Web site at: http://www.effectivehealthcare.ahrq.gov/index.cfm/call-for-abstracts-rare-diseases/
Effective Health Care Program http://effectivehealthcare.ahrq.gov

ICPE 2013 - Notifications emailed to abstract submitters; deadline for acceptance June 12

Confirmation of acceptances must be emailed directly to Coe-Truman by June 12. If we do not hear from you by JUNE 12, the Scientific Program Committee will reassign this time slot to another presenter.



International Pharmacoepidemiology Legislation

ANNUAL MEMBERS

Pharmaceuticals

  • F. Hoffmann-LaRoche AG
  • GlaxoSmithKline
  • Sanofi-Aventis
Service Providers
  • RTI Health Solutions
Government/Regulatory Agency
  • Department of Health, Pharmaceutical Services, Hong Kong Special Administrative Region, People's Republic of China
  • Drug Safety and Effectiveness Network, Canadian Institute of Health Research

Academic Programs

  • Center for Pharmacoepidemiology Research and Training (CPeRT), Pereleman School of Medicine at the University of Pennsylvania
  • Center for Drug Safety & Pharmaceutical Health Services Research Graduate Program, University of Maryland School of Pharmacy
  • Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida
  • Division of Pharmacoepidemiology & Pharmacoeconomics, Brigham and Women's Hospital & Harvard Medical School
  • Drug Safety Research Unit, Associated Department, School of Pharmacy, Portsmouth University
  • Harvard School of Public Health
  • London School of Hygiene and Tropical Medicine
  • McGill Pharmacoepidemiology Research Unit, McGill University
  • Pharmacoepidemiology Program, Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill
  • Regenstrief Institute
  • Slone Epidemiology Center, Boston University


Join ISPE's Mailing List!
For Email Newsletters you can trust





Euro-Durg




COPYRIGHT 2013 INTERNATIONAL SOCIETY FOR PHARMACOEPIDEMIOLOGY
5272 River Road, Suite 630, Bethesda, MD 20816 USA
Phone: 301-718-6500, Fax: 301-656-0989, Email: ISPE@paimgmt.com
 
Privacy Policy
Terms of Use / Disclaimer Statement
Infinite Menus, Copyright 2006, OpenCube Inc. All Rights Reserved.